Executive Interviews

The primary purpose of the Rental Management Investment Trust (RMIT) is to invest in the Rental Management Australia Fund (RMA Fund). The RMA Fund is an unlisted stapled investment comprising of the Rental Management Australia Group Ltd (RMA Group) and the Rental Management Australia Trust (RMA Trust).

Bio-Gene Technology is a W.A. biotech company that has discovered a natural organic insecticide in the leaves of an Australian Eucalypt tree called Qcide. Qcide produces 100% mortality in insects yet is non-toxic to mammals, birds, and reptiles making it a very safe and effective alternative to some compounds in the world today.

Cellmid (ASX: CDY) develops innovative therapies and diagnostics for cancer, inflammation and heart attack. CDY has the largest global IP portfolio related to growth factor midkine (MK). Its most advanced program is for MK antibodies targeting cancer/inflammation. CDY is also developing MK protein to treat heart attack and other ischemia.

Wizard Power develops world leading Concentrating Solar Power (CSP) technology and licenses it to developers of large-scale energy projects. Its core product is the Big Dish, a multi-purpose, ultra high temperature solar energy delivery platform that provides the world’s most competitive on-demand utility scale solar energy. Aside from electricity generation, it also provides energy for […]

Optiscan is a global leader in the development and application of miniaturised microscopic imaging technologies for medical markets. Optiscan’s imaging technology allows live cellular imaging for earlier and better detection of pre-cancerous and cancerous lesions and more accurate resection during surgery. Optiscan’s technology has been incorporated into Pentax endoscopes since 2006 and will soon be […]

Over the past four years, Syngas Limited (ASX:SYS) has invested in and established a biomass/clean energy business (BioSyngas Pty Ltd) on the basis that commercial opportunities would be created through the introduction of carbon management initiatives in Australia. Syngas has now reached the stage where a separate entity, BioSyngas Pty Ltd, is ready to launch, […]

Capita Asset Management Limited is a Brisbane based funds management company specialising in property syndicates and mortgage lending. The company’s latest investment offer is the ‘Capita Adelaide Street Trust’ which is being formed to acquire and develop an approved 8 Lot residential subdivision in Clayfield, Brisbane.

Life Science sector represents the essential industry for Wholesale Investor. A great number of small, medium and start-up life science enterprises are directly promoted to active investors and deal makers.

AIMEDICS has developed the HypoMon which is the world’s first non-invasive night time low blood glucose management system. More than 11 million diabetic insulin users in the developed world suffer from bouts of dangerously low blood glucose several nights per month. Independent USA market research indicates that the HypoMon is a unique product addressing a […]